...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Rock Stars still rocking it

It was great to see the Rock Star 2nd cohort are still going after 64 weeks with PSA's still below 1.

would have been nice to have more info on the financing but we will find out soon enough.

tada

Share
New Message
Please login to post a reply